Sort
261,768 grants matching “gene therapy”
Gene Targets for Intraventricular Hemorrhage (IVH)
$1,571,696Laura R. Ment · Yale University · R01 · FY2009 · NS
Early Events in KSVH Infection of Primary B-cells
$1,571,505Erle S Robertson · University Of Pennsylvania · P01 · FY2017 · CA
Development of Gleevec for TB and TB/HIV
$1,571,205Daniel Kalman · Emory University · UH3 · FY2019 · AI
TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant
$1,571,078David S Wilkes · Indiana University Indianapolis · P01 · FY2014 · AI
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy
$1,570,974Eric P Hoffman · Children'S Research Institute · P50 · FY2012 · AR
Pig to Non-Human Primate Islet Xenografts
$1,570,841Judith M. Thomas · University Of Alabama At Birmingham · U19 · FY2006 · AI
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
$1,570,828Oklahoma Medical Research Foundation · P50 · FY2001 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,570,521Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Etiology of Treatment Induced Secondary Leukemia
$1,570,439University Of Chicago · P01 · FY2003 · CA
CD28-KITv CAR T cells with PD-1 dominant negative receptor
$1,570,342Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · UG3 · FY2025 · CA
Expression Genetics in Drug Therapy
$1,570,156Wolfgang Sadee · Ohio State University · U01 · FY2011 · GM
DNA Vaccines
$1,570,101George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanisms of Esophageal Carcinogenesis
$1,569,941Anil K Rustgi · Columbia University Health Sciences · P01 · FY2023 · CA
Disease mechanism and therapies for retinal degeneration
$1,569,922Tiansen Li · National Eye Institute · ZIA · FY2018 · EY
Proteases in Cancer Biology and Drug Development
$1,569,832Zena Werb · University Of California, San Francisco · P01 · FY2007 · CA
Center for the Neurobiology of Addiction Treatment
$1,569,610Michael A Nader · Wake Forest University Health Sciences · P50 · FY2016 · DA
NINDS Cooperative Program in Translational Research
$1,569,553Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2012 · NS
Development of Toll-Like Receptor Agonists as Neuroprotectants in Brain Ischemia
$1,569,553Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2012 · NS
Model Systems for Development of Pain Gene Therapy
$1,568,715Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · DK
Complex Neurodegenerative Disorders Clinic
$1,568,562Justin Kwan · National Institute Of Neurological Disorders And Stroke · ZID · FY2022 · NS
Etiology and Treatment of Alcohol Dependence
$1,568,084Victor M Hesselbrock · University Of Connecticut Sch Of Med/Dnt · P60 · FY2017 · AA
Antigen-targeted activation of Topo1 inhibitors via click chemistry
$1,568,070Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2024 · CA
Radiation Bystander Effects: Mechanisms
$1,567,789Tom K Hei · Columbia University Health Sciences · P01 · FY2014 · CA
Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle
$1,567,752Jeffrey S Chamberlain · University Of Washington · U54 · FY2016 · AR
Molecular Genetics Support to Identify Gene/Environment Interactions in Disease
$1,567,713John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIC · FY2018 · ES